Sales and Marketing

Showing 15 posts of 11524 posts found.

handshake

Amgen agrees deal to commercialise biosimilars in Japan with Daiichi Sankyo

July 14, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Daiichi Sankyo, Japan, biosimilars

Amgen (NASDAQ: AMGN) has agreed a deal with Daiichi Sankyo (TSE: 4568) that will see the pair commercialise nine biosimilars …

FDA recommends Novartis’s biosimilar for Enbrel in unanimous vote

July 14, 2016 Research and Development, Sales and Marketing Enbrel, FDA, Novartis, Sandoz, biosimilar

Sandoz, a division of Novartis, has announced that a US Food and Drug Administration (FDA) advisory committee has recommended their …
fda_logo-web

US FDA committee recommends approval for Amgen’s biosimilar of AbbVie’s Humira

July 13, 2016 Research and Development, Sales and Marketing AbbVie, Amgen, Humira, US FDA, biosimilar, drug approval, drug trial, inflammatory diseases, rheumatoid arthritis

One of the world’s bestselling drug may soon have competition in the US markets after the regulators backed a biosimilar …
junologo

US FDA lifts hold on Juno’s CAR-T therapy trials; shares jump

July 13, 2016 Research and Development, Sales and Marketing Stock Price, US FDA, drug trial, juno therapeutics

Shares in Juno Therapeutics (Nasdaq: JUNO) jumped to close up almost 30% after the company said the US Food and …

Pfizer gets approval expansion from FDA for pneumonia vaccine

July 13, 2016 Research and Development, Sales and Marketing FDA, Pfizer, Prevnar 13, adults, approval

The US Food and Drug Administration (FDA) has issued an expanded approval for Pfizer’s pneumococcal pneumonia vaccine Prevnar 13 to …

Scottish regulators back BMS’ Opdivo for lung cancer

July 13, 2016 Research and Development, Sales and Marketing Bristol-Myers Sqibb, NICE, Scottish Medicines Consortium, lung cancer, opdivo, regulation

Bristol-Myers Squibb (NYSE: BMY) said the Scottish Medicines Consortium (SMC) has recommended cancer immunotherapy Opdivo (nivolumab) to treat advanced squamous …

Nice backs UCB’s Cimzia as alternate therapy for severe rheumatoid arthritis

July 13, 2016 Research and Development, Sales and Marketing Cimzia, NICE, UCB, regulation, rheumatoid arthritis

The National Institute for Health and Care Excellence (Nice) has recommended UCB Pharma’s Cimzia (certolizumab pegol) on its own or …
logo

AstraZeneca mulling a $10-billion bid for Medivation – report

July 12, 2016 Manufacturing and Production, Sales and Marketing AstraZeneca, Celgene, Medivation, Pfizer, Xtandi, cancer drug, merger and acquisition

Anglo Swedish drug firm AstraZeneca (LSE: AZN) is considering a $10-billion takeover bid for Medivation (Nasdaq: MDVN), according to reports. …
amgen_flag

FDA approves single monthly injection of Amgen’s Repatha

July 12, 2016 Manufacturing and Production, Sales and Marketing Amgen, FDA, Repatha, pushtronex

Amgen (NASDAQ: AMGN) has announced that the US Food and Drug Administration (FDA) has approved a new, monthly single-dose administration …
cancerstudy

Coherus BioSciences says Neulasta biosimilar shows positive topline results; shares jump

July 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cancer, Coherus BioSciences, biosimilar, drug trial

Shares in Coherus BioSciences (Nasdaq: CHRS) jumped to close over 27% after the company said its biosimilar copy for Amgen’s …
shire_image_4

Shire dry eye treatment gets FDA approval

July 12, 2016 Manufacturing and Production, Sales and Marketing FDA, Shire, dry eye, xiidra

Shire (LSE: SHP) has announced that the US Food and Drug Administration has approved its twice-daily eye drop solution, Xiidra …
davidmeek

Ipsen’s CEO to step down, names new chief executive

July 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen (Euronext: IPN) said its chief executive Marc de Garidel is stepping down and will be replaced by David Meek, …

Zydus nabs FDA approval for type-2 diabetes drug

July 11, 2016 Sales and Marketing Zydus Cadila, nateglinide

Zydus Cadila, a division of Cadila Pharmaceuticals (NSE: CADILAHC), has announced the US Food and Drug Administration (FDA) has approved …
dollars_medicines

Opponents of new Medicare reforms received far more in pharma contributions, claims report

July 11, 2016 Medical Communications, Sales and Marketing corporate donations, public citizen

A new report has emerged highlighting the extent to which opponents and critics of the Obama administration’s reforms of Medicare …
The Gateway to Local Adoption Series

Latest content